DK0815231T3 - Anvendelse af neuronalt apoptosisinhibitorprotein (NAIP) - Google Patents

Anvendelse af neuronalt apoptosisinhibitorprotein (NAIP)

Info

Publication number
DK0815231T3
DK0815231T3 DK97902522T DK97902522T DK0815231T3 DK 0815231 T3 DK0815231 T3 DK 0815231T3 DK 97902522 T DK97902522 T DK 97902522T DK 97902522 T DK97902522 T DK 97902522T DK 0815231 T3 DK0815231 T3 DK 0815231T3
Authority
DK
Denmark
Prior art keywords
naip
inhibitor protein
apoptosis inhibitor
neuronal apoptosis
apoptosis
Prior art date
Application number
DK97902522T
Other languages
English (en)
Inventor
Robert G Korneluk
Alexander E Mackenzie
George Robertson
Natalie Roy
Original Assignee
Univ Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ottawa filed Critical Univ Ottawa
Application granted granted Critical
Publication of DK0815231T3 publication Critical patent/DK0815231T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
DK97902522T 1996-01-19 1997-01-17 Anvendelse af neuronalt apoptosisinhibitorprotein (NAIP) DK0815231T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9601108.5A GB9601108D0 (en) 1996-01-19 1996-01-19 Neuronal apoptosis inhibitor protein (NAIP)

Publications (1)

Publication Number Publication Date
DK0815231T3 true DK0815231T3 (da) 2005-12-12

Family

ID=10787268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902522T DK0815231T3 (da) 1996-01-19 1997-01-17 Anvendelse af neuronalt apoptosisinhibitorprotein (NAIP)

Country Status (11)

Country Link
US (2) US6994957B2 (da)
EP (2) EP1609864A3 (da)
JP (1) JP4005135B2 (da)
AT (1) ATE301192T1 (da)
AU (1) AU1614997A (da)
CA (1) CA2215793C (da)
DE (1) DE69733861T2 (da)
DK (1) DK0815231T3 (da)
ES (1) ES2245790T3 (da)
GB (1) GB9601108D0 (da)
WO (1) WO1997026331A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156535A (en) 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
GB9601108D0 (en) * 1996-01-19 1996-03-20 Univ Ottawa Neuronal apoptosis inhibitor protein (NAIP)
US6159948A (en) * 1996-04-26 2000-12-12 University Of Ottawa Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
US6133437A (en) 1997-02-13 2000-10-17 Apoptogen, Inc. Modulation of IAPs for the treatment of proliferative diseases
JPH11116599A (ja) * 1997-10-14 1999-04-27 Japan Science & Technology Corp アポトーシス抑制蛋白質とこの蛋白質をコードする 遺伝子およびそのｃＤＮＡ
US6171821B1 (en) * 1998-07-24 2001-01-09 Apoptogen, Inc. XIAP IRES and uses thereof
JP2000125861A (ja) 1998-10-26 2000-05-09 Japan Science & Technology Corp ヒト・アポトーシス抑制蛋白質ｎａｉｐに対する モノクローナル抗体と、ｎａｉｐの検定方法
US6673917B1 (en) 2000-09-28 2004-01-06 University Of Ottawa Antisense IAP nucleic acids and uses thereof
CN1656222B (zh) 2002-03-27 2011-11-30 艾格拉治疗公司 反义iap核碱基寡聚物及其应用
US8012944B2 (en) 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
CA2591474A1 (en) * 2004-11-10 2006-05-18 Neugen Pharma, Inc. Therapeutic or preventive agents for ischemic heart disease or ischemic cardiomyopathy
DK1889065T3 (da) 2005-05-18 2013-09-02 Xoma Technology Ltd Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent
KR101779370B1 (ko) 2016-06-29 2017-09-19 한국수력원자력 주식회사 방사선 조사 된 흉선 림프종 세포에서 발굴 된 세포고사 조절 유전자 및 그 검출방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332798T2 (de) 1992-09-14 2004-02-12 The General Hospital Corp., Boston Ikaros: ein regulatorisches gen bei der t-zell differenzierung
DE69534629D1 (de) 1994-01-18 2005-12-29 Scripps Research Inst Derivate von zinkfingerproteinen und methoden
US6020127A (en) 1994-10-18 2000-02-01 The University Of Ottawa Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy
US6156535A (en) 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
US5919912A (en) 1995-08-04 1999-07-06 University Of Ottawa Mammalian IAP antibodies and diagnostic kits
GB9601108D0 (en) 1996-01-19 1996-03-20 Univ Ottawa Neuronal apoptosis inhibitor protein (NAIP)
US6133437A (en) 1997-02-13 2000-10-17 Apoptogen, Inc. Modulation of IAPs for the treatment of proliferative diseases

Also Published As

Publication number Publication date
GB9601108D0 (en) 1996-03-20
AU1614997A (en) 1997-08-11
CA2215793A1 (en) 1997-07-24
DE69733861T2 (de) 2006-05-24
CA2215793C (en) 2005-07-05
US20020137028A1 (en) 2002-09-26
EP0815231B1 (en) 2005-08-03
US6994957B2 (en) 2006-02-07
WO1997026331A2 (en) 1997-07-24
DE69733861D1 (de) 2005-09-08
EP1609864A2 (en) 2005-12-28
US20060172348A1 (en) 2006-08-03
EP0815231A2 (en) 1998-01-07
US7235372B2 (en) 2007-06-26
ATE301192T1 (de) 2005-08-15
EP1609864A3 (en) 2007-12-12
JPH11503620A (ja) 1999-03-30
WO1997026331A3 (en) 1997-10-02
ES2245790T3 (es) 2006-01-16
JP4005135B2 (ja) 2007-11-07

Similar Documents

Publication Publication Date Title
DK0815231T3 (da) Anvendelse af neuronalt apoptosisinhibitorprotein (NAIP)
DK1028729T3 (da) Fremgangsmåder til modulering af serin/threoninproteinkinasefunktion med 5-azaquinoxalinbaserede forbindelser
DE69806981D1 (de) Verfahren zur Kontrastverbesserung von Bildsequenzen
DE69428381D1 (de) System zur Inspection von optischen Bauelementen
EP0892048A3 (en) XAF genes and polypeptides and their use for modulating apoptosis
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
DE69731707D1 (de) Verfahren zum Korrigieren von der ungleichen Position einer Informationsscheibe
WO1999019513A3 (en) Methods for detecting compounds which modulate the activity of an lpa receptor
DE69524008D1 (de) Vorrichtung zur optischen Aufzeichnung von Information
DE60334246D1 (de) Modulieren von immunantworten
EP1032837A4 (en) TARGET SEQUENCES FOR SYNTHETIC MOLECULES AND METHODS OF USING THE SAME
BR9708347A (pt) Compostos de tetrahidorbeta-carbonila
DE69222710D1 (de) Verfahren zum Nachweis von DNS-Basen mit Verwendung von Fluoreszenz
TR199801823T2 (en) B�cek �ld�r�c� kar���mlar.
DE69631230D1 (de) Kodediskriminierungssystem zur schnellen Ermittlung der Kodeübereinstimmung
DE69606837D1 (de) Gerät zur Überprüfung der Bestimmungen von klinischen Analysen
DK0785949T3 (da) Fremgangsmåde til oprensning af keratinocytvækstfaktorer
DE69820942T2 (de) Verfahren zum Steuern der Tonerkonzentration
DE69710144D1 (de) Einrichtung zur Erfassung von optischen Pulsen
DE69807148D1 (de) Verfahren zur Hydroformylierung von Olefininen
DE59812587D1 (de) System zur optischen Übertragung von Informationen
NO992107D0 (no) FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet
DE59910237D1 (de) Verfahren zur automatischen taktfreien Erkennung von Signal-Modulationsarten
DE69806107D1 (de) Methoden und reagenzien zur regulierung von apoptosis
DE69719726D1 (de) Verfahren zur Detektion von Leukämie